about
Value of black blood T2* cardiovascular magnetic resonance.Reproductive capacity in iron overloaded women with thalassemia major.A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing.β-Thalassemia and ocular implications: a systematic review.International survey of T2* cardiovascular magnetic resonance in β-thalassemia majorIron chelation therapy in the management of transfusion-related cardiac iron overload.Iron metabolism: interactions with normal and disordered erythropoiesisNew updating into hemoglobinopathies.The current status of β-thalassemia major in Mainland China.Diagnosis and prevention of thalassemia.Thalassemia 2016: Modern medicine battles an ancient disease.The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?Changes in the quality of life of people with thalassemia major between 2001 and 2009.Hematological malignancies complicating β-thalassemia syndromes: a single center experience.Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical TrialIn search of the optimal iron chelation therapy for patients with thalassemia major.Are people getting quality thalassemia care in twin cities of Pakistan? A comparison with international standards.Evaluation of hepatic iron overload in Chinese children with β-thalassemia major.Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian WEBTHAL project.
P2860
Q34706719-C91FEDFC-DEC6-4F60-B655-E4B94CDEB45DQ35212404-4DF7316F-A3EE-4839-B972-247BCF245924Q35367747-450B00C2-438F-4B7F-BABD-8F5CFD38EDF0Q36070750-6365ACE8-9194-4496-9C42-6A876C98331AQ37144860-32E13120-CD22-4660-A45A-3C005476425AQ37992181-C083EF4F-DE23-43A0-A154-1B9A2E9E0F50Q38007163-CB8F6490-ED80-4F2A-9C79-BC0CBFDA14FEQ38023896-AA59863B-C8E4-474B-A4FB-99D06A8D480AQ38099694-B1151D16-930E-4083-8573-649CFFCA7CCAQ38167823-A313FE99-E2CF-4928-AD1C-FC02DFE49CAAQ38625435-D763F855-E2E7-4A04-87FE-0E7D643B28D2Q38810873-63EFD6FB-69C4-4D85-B456-4B53B6EED788Q39566789-64D8677C-709D-41DC-886B-7B84A5133956Q41368355-01C502D2-F67D-4E1B-A2CD-ADA208C3080DQ42098491-55F51572-8A99-4B28-9E7C-17C8E46A783EQ42558429-D1B471D1-FA4F-4D36-8F7C-790AD755FCD6Q48515785-7EB69D2D-1112-43BB-980C-2B2C4EB2A9FEQ50525194-BB3C9922-AC88-4F0D-9115-F58BD429ADFBQ51877530-A1A1A209-3BC7-4D9E-A63D-ECCD7A1D27A6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on survival in thalassemia major.
@en
Update on survival in thalassemia major.
@nl
type
label
Update on survival in thalassemia major.
@en
Update on survival in thalassemia major.
@nl
prefLabel
Update on survival in thalassemia major.
@en
Update on survival in thalassemia major.
@nl
P2860
P1433
P1476
Update on survival in thalassemia major.
@en
P2093
Paul Telfer
P2860
P304
P356
10.3109/03630260903347336
P478
33 Suppl 1
P577
2009-01-01T00:00:00Z